Novartis is making two investments in new radiopharmaceutical manufacturing sites in the US. The Swiss pharmaceutical giant will open a third US radioligand plant in Carlsbad, California, to serve the ...

Issuance is expected to increase before the US election, after several borrowers decided to come to market in advance of the ...

Bausch Health is rumored to be looking to sell its Bausch + Lomb business, which will ease bankruptcy concerns and upgrade ...

Bank of America is the national presenting sponsor and Walgreens, Novartis and Lilly are national series sponsors for the MORE THAN PINK Walk and Race for the Cure events. Join us at the San Antonio ...

The decision to use b/tsDMARD monotherapy vs combination therapy with MTX when treating PsA is primarily based on patient satisfaction and drug tolerability.

Time spent above, not below, the target glucose range was associated with mortality in a study of adults with type 2 diabetes ...

Women with early-stage breast cancer may now take Kisqali, a medication already approved for advanced disease, following the ...

Susac syndrome is a rare inflammatory vascular endotheliopathy affecting the small vessels of the brain, eye, and ear.1,2 ...

The breast cancer drug Kisqali has received FDA approval to reduce cases of cancer recurrence. The drug was found to reduce ...

In the obesity drug industry, two players have really been throwing their weight around. There isn’t a third in sight.